Valley National Advisers’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Sell
7,979
-96
-1% -$20.6K 0.19% 101
2026
Q1
$1.78M Buy
8,075
+55
+0.7% +$13.5K 0.23% 91
2025
Q4
$2.03M Sell
8,020
-245
-3% -$61.5K 0.28% 86
2025
Q3
$2.04M Buy
+8,265
New +$1.98M 0.32% 90
2024
Q3
Sell
-7
Closed -$1K 1096
2024
Q2
$1K Sell
7
-8
-53% -$1.74K ﹤0.01% 1131
2024
Q1
$3K Hold
15
﹤0.01% 901
2023
Q4
$3K Buy
15
+10
+200% +$2.12K ﹤0.01% 895
2023
Q3
$1K Buy
+5
New +$1.13K ﹤0.01% 1015

Other funds holding STE

Valley National Advisers's STE Position: Q2 2026 in Review

Valley National Advisers reduced its Steris (STE) stake by 1.2% in Q2 2026, selling an estimated $20.6K and leaving 7,979 shares worth $1.68M. The position accounts for 0.19% of the portfolio, ranked #101.

Valley National Advisers first reported a position in STE in Q3 2023 and has held it in 8 quarters since. The position peaked at $2.04M in Q3 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Valley National Advisers held 7,979 shares of Steris worth $1.68M as of Q2 2026.
  • Valley National Advisers sold 96 Steris shares in Q2 2026, an estimated $20.6K.
  • Steris made up 0.19% of Valley National Advisers's portfolio in Q2 2026, its #101 holding.
  • Valley National Advisers first reported a position in Steris in Q3 2023 and has held it in 8 quarters since.
  • Valley National Advisers's Steris position peaked at $2.04M in Q3 2025.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.